Functional assessment of peptide-modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis
- 1 March 2019
- journal article
- conference paper
- Published by Elsevier in Journal of Controlled Release
- Vol. 297, 3-13
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Dental and Craniofacial Research (R01DE023206, R21DE025345)
- NIH COBRE (GM125504)
This publication has 57 references indexed in Scilit:
- Porphyromonas gingivalis Facilitates the Development and Progression of Destructive Arthritis through Its Unique Bacterial Peptidylarginine Deiminase (PAD)PLOS Pathogens, 2013
- Multivalency as a Chemical Organization and Action PrincipleAngewandte Chemie International Edition, 2012
- Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriersAdvanced Drug Delivery Reviews, 2012
- Low-Abundance Biofilm Species Orchestrates Inflammatory Periodontal Disease through the Commensal Microbiota and ComplementCell Host & Microbe, 2011
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery CarrierPolymers, 2011
- Expression of toll‐like receptors 2, 4 and 9 is increased in gingival tissue from patients with type 2 diabetes and chronic periodontitisJournal of Periodontal Research, 2011
- Structural Dissection and In Vivo Effectiveness of a Peptide Inhibitor of Porphyromonas gingivalis Adherence to Streptococcus gordoniiInfection and Immunity, 2011
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdvanced Drug Delivery Reviews, 2009
- Interaction of Porphyromonas gingivalis with Oral Streptococci Requires a Motif That Resembles the Eukaryotic Nuclear Receptor Box Protein-Protein Interaction DomainInfection and Immunity, 2008
- Structural Characterization of Peptide-Mediated Inhibition of Porphyromonas gingivalis Biofilm FormationInfection and Immunity, 2006